1. Home
  2. CDXS vs FVCB Comparison

CDXS vs FVCB Comparison

Compare CDXS & FVCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • FVCB
  • Stock Information
  • Founded
  • CDXS 2002
  • FVCB 2007
  • Country
  • CDXS United States
  • FVCB United States
  • Employees
  • CDXS N/A
  • FVCB N/A
  • Industry
  • CDXS Major Chemicals
  • FVCB Major Banks
  • Sector
  • CDXS Industrials
  • FVCB Finance
  • Exchange
  • CDXS Nasdaq
  • FVCB Nasdaq
  • Market Cap
  • CDXS 201.3M
  • FVCB 204.0M
  • IPO Year
  • CDXS 2010
  • FVCB N/A
  • Fundamental
  • Price
  • CDXS $3.04
  • FVCB $13.20
  • Analyst Decision
  • CDXS Buy
  • FVCB Buy
  • Analyst Count
  • CDXS 2
  • FVCB 1
  • Target Price
  • CDXS $11.00
  • FVCB $16.00
  • AVG Volume (30 Days)
  • CDXS 910.6K
  • FVCB 58.6K
  • Earning Date
  • CDXS 08-07-2025
  • FVCB 07-24-2025
  • Dividend Yield
  • CDXS N/A
  • FVCB N/A
  • EPS Growth
  • CDXS N/A
  • FVCB 311.46
  • EPS
  • CDXS N/A
  • FVCB 1.03
  • Revenue
  • CDXS $49,815,000.00
  • FVCB $60,453,000.00
  • Revenue This Year
  • CDXS $12.77
  • FVCB $8.48
  • Revenue Next Year
  • CDXS $22.12
  • FVCB $7.88
  • P/E Ratio
  • CDXS N/A
  • FVCB $12.64
  • Revenue Growth
  • CDXS N/A
  • FVCB 34.53
  • 52 Week Low
  • CDXS $1.90
  • FVCB $9.49
  • 52 Week High
  • CDXS $6.08
  • FVCB $14.50
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 69.54
  • FVCB 71.42
  • Support Level
  • CDXS $2.55
  • FVCB $12.88
  • Resistance Level
  • CDXS $2.91
  • FVCB $13.62
  • Average True Range (ATR)
  • CDXS 0.20
  • FVCB 0.40
  • MACD
  • CDXS 0.06
  • FVCB 0.14
  • Stochastic Oscillator
  • CDXS 96.17
  • FVCB 81.43

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

Share on Social Networks: